These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17235570)

  • 1. Sertoli-Leydig cell tumours of the ovary and testis: a CGH and FISH study.
    Verdorfer I; Horst D; Höllrigl A; Rogatsch H; Mikuz G
    Virchows Arch; 2007 Mar; 450(3):267-71. PubMed ID: 17235570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trisomy 8 as sole karyotypic aberration in an ovarian metastasizing Sertoli-Leydig cell tumor.
    Manegold E; Tietze L; Günther K; Fleischer A; Amo-Takyi BK; Schröder W; Handt S
    Hum Pathol; 2001 May; 32(5):559-62. PubMed ID: 11381376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains.
    Acosta AM; Sholl LM; Maclean F; Kao CS; Ulbright TM
    Mod Pathol; 2024 Jan; 37(1):100368. PubMed ID: 37871653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic evidence supporting the neoplastic nature of the Leydig cell component of ovarian Sertoli-Leydig cell tumors.
    Emerson RE; Wang M; Roth LM; Zheng W; Abdul-Karim FW; Liu F; Ulbright TM; Eble JN; Cheng L
    Int J Gynecol Pathol; 2007 Oct; 26(4):368-74. PubMed ID: 17885485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertoli-Leydig cell tumour complicated by X chromosomal mosaicism.
    Hitosugi M; Matsuoka Y; Irimajiri S; Fukuda J
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):619-22. PubMed ID: 9425402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of
    Golmard L; Vasta LM; Duflos V; Corsini C; Dubois d'Enghien C; McMaster ML; Harney LA; Carr AG; Ling A; Dijoud F; Gauthier A; Miettinen M; Cost NG; Gauthier-Villars M; Orbach D; Irtan S; Haouy S; Schultz KA; Stoppa-Lyonnet D; Coupier I; Stewart DR; Sirvent N
    J Med Genet; 2022 Apr; 59(4):346-350. PubMed ID: 33782093
    [No Abstract]   [Full Text] [Related]  

  • 7. Endometrioid-like yolk sac and Sertoli-Leydig cell tumors in a carrier of a Y heterochromatin insertion into 1qh region: a causal association?
    Sala E; Villa N; Crosti F; Miozzo M; Perego P; Cappellini A; Bonazzi C; Barisani D; Dalprà L
    Cancer Genet Cytogenet; 2007 Mar; 173(2):164-9. PubMed ID: 17321334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
    Virk R; Lu D
    Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular-cytogenetic characterisation of sex cord-stromal tumours: CGH analysis in sertoli cell tumours of the testis.
    Verdorfer I; Höllrigl A; Strasser U; Susani M; Hartmann A; Rogatsch H; Mikuz G
    Virchows Arch; 2007 Apr; 450(4):425-31. PubMed ID: 17333264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhenoblastoma in first cousins. Report of 2 cases.
    Goldstein DP; Lamb EJ
    Obstet Gynecol; 1970 Mar; 35(3):444-50. PubMed ID: 4313620
    [No Abstract]   [Full Text] [Related]  

  • 11. Relaxin-like factor expression in a human ovarian Sertoli-Leydig cell tumor.
    Klonisch T; Hombach-Klonisch S; Buchmann J; Fischer B; Bergmann M; Steger K
    Fertil Steril; 1999 Sep; 72(3):546-8. PubMed ID: 10519633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian Sertoli-Leydig cell tumor: a SRY gene-independent pathway of pseudomale gonadal differentiation.
    Hittmair A; Zelger BG; Obrist P; Dirnhofer S
    Hum Pathol; 1997 Oct; 28(10):1206-10. PubMed ID: 9343329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from genomic profiling: towards a molecular-based classification of ovarian Sertoli-Leydig cell tumour.
    Kommoss FKF
    Histopathology; 2024 Mar; 84(4):712-714. PubMed ID: 38114269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour.
    Kim MS; Lee SH; Yoo NJ; Lee SH
    Histopathology; 2013 Sep; 63(3):436-8. PubMed ID: 23763383
    [No Abstract]   [Full Text] [Related]  

  • 16. Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings.
    Mooney EE; Nogales FF; Bergeron C; Tavassoli FA
    Histopathology; 2002 Aug; 41(2):110-7. PubMed ID: 12147087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative tumour pathology of the ovary and testis.
    Zajicek J
    Monogr Clin Cytol; 1979; 7():38-53. PubMed ID: 223040
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells.
    Mooney EE; Nogales FF; Tavassoli FA
    Hum Pathol; 1999 Jun; 30(6):611-7. PubMed ID: 10374766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertoli-Leydig cell tumor of the ovary--morphological and immunohistochemical analysis.
    Durdík Š; Danihel L; Galbavý Š
    Neuro Endocrinol Lett; 2012; 33(3):257-9. PubMed ID: 22635079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in Sertoli-Leydig cell tumour of the ovary].
    Shi JL; Guo LN; Lang JH
    Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):631-3. PubMed ID: 19094590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.